We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4.92B
AUM Growth
+$1.62B
Cap. Flow
+$1.41B
Cap. Flow %
28.67%
Top 10 Hldgs %
36.75%
Holding
1,419
New
468
Increased
176
Reduced
163
Closed
410

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$208M
2
AMZN icon
Amazon
AMZN
+$165M
3
AMD icon
Advanced Micro Devices
AMD
+$86.9M
4
XYZ
Block Inc
XYZ
+$33.2M
5
ROKU icon
Roku
ROKU
+$27M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$10.3M
2
MRNA icon
Moderna
MRNA
+$9.79M
3
JD icon
JD.com
JD
+$6.14M
4
AZN icon
AstraZeneca
AZN
+$5.27M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.32M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.5%
2 Technology 4.33%
3 Communication Services 2.49%
4 Healthcare 1.87%
5 Financials 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DQ
1101
PUT
Daqo New Energy
DQ
$810M
– –
-13,000
Closed -$741K
DT icon
1102
PUT
Dynatrace
DT
$12.7B
– –
-50,000
Closed -$3.55M
DVAX
1103
PUT
DELISTED
Dynavax Technologies
DVAX
– –
-15,000
Closed -$288K
DVN icon
1104
CALL
Devon Energy
DVN
$51.3B
– –
-10,000
Closed -$355K
EAF icon
1105
CALL
GrafTech
EAF
$184M
– –
-4,000
Closed -$413K
EAF icon
1106
GrafTech
EAF
$184M
– –
-350
Closed -$36K
EDU icon
1107
CALL
New Oriental
EDU
$9.32B
– –
-8,000
Closed -$164K
EHC icon
1108
PUT
Encompass Health
EHC
$11.3B
– –
-6,285
Closed -$375K
EIX icon
1109
PUT
Edison International
EIX
$30.3B
– –
-30,000
Closed -$1.66M
ELV icon
1110
Elevance Health
ELV
$81.5B
– –
-2,000
Closed -$746K
ENTA icon
1111
CALL
Enanta Pharmaceuticals
ENTA
$362M
– –
-11,600
Closed -$659K
ESTC icon
1112
Elastic
ESTC
$6.7B
– –
-2,000
Closed -$298K
ETSY icon
1113
CALL
Etsy
ETSY
$8.12B
– –
-90,500
Closed -$18.8M
EVRI
1114
CALL
DELISTED
Everi Holdings
EVRI
– –
-100,000
Closed -$2.42M
EW icon
1115
CALL
Edwards Lifesciences
EW
$49.4B
– –
-10,000
Closed -$1.13M
FBRX icon
1116
CALL
Forte Biosciences
FBRX
$1.57B
– –
-160
Closed -$12K
FBRX icon
1117
Forte Biosciences
FBRX
$1.57B
– –
-200
Closed -$15K
FBRX icon
1118
PUT
Forte Biosciences
FBRX
$1.57B
– –
-416
Closed -$31K
FCX icon
1119
CALL
Freeport-McMoran
FCX
$86.2B
– –
-27,700
Closed -$901K
FDX icon
1120
FedEx
FDX
$73B
– –
-1,000
Closed -$219K
FDX icon
1121
PUT
FedEx
FDX
$73B
– –
-10,000
Closed -$2.19M
FIVN icon
1122
CALL
FIVE9
FIVN
$2.08B
– –
-26,700
Closed -$4.26M
FIVN icon
1123
FIVE9
FIVN
$2.08B
– –
-18,500
Closed -$2.96M
FMX icon
1124
Fomento Económico Mexicano
FMX
$41.2B
– –
-2,500
Closed -$217K
FMX icon
1125
PUT
Fomento Económico Mexicano
FMX
$41.2B
– –
-9,000
Closed -$780K
43 44
45
46 47

Similar funds

EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

SG3 Management's Q4 2021 Portfolio in Review

As of Q4 2021, SG3 Management held 1,419 positions worth $4.92B, up 49% from $3.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

SG3 Management deployed $1.41B of net new capital in Q4 2021, opening 468 new positions and adding to 176 existing holdings. Its largest new stake was Tesla: 619,500 shares worth $218M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.5% of assets, up from 0.74% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Moderna, an estimated $9.79M trimmed.

  • SG3 Management's largest Q4 2021 buy was Tesla: 619,500 shares worth $218M.
  • SG3 Management added most to Amazon in Q4 2021, an estimated $165M increase.
  • SG3 Management's biggest Q4 2021 reduction was Moderna, cutting an estimated $9.79M.
  • SG3 Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $10.3M.
  • SG3 Management's ten largest holdings make up 37% of its $4.92B portfolio in Q4 2021.
  • SG3 Management opened 468 new positions and closed 410 in Q4 2021.
  • SG3 Management's portfolio value rose 49% quarter-over-quarter to $4.92B.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.